Soleno Therapeutics, Inc. (SLNO) Misses Q1 EPS by 6c

Soleno Therapeutics, Inc. (NASDAQ: SLNO) reported Q1 EPS of ($0.95), $0.06 worse than the analyst estimate of ($0.89).

For earnings history and earnings-related data on Soleno Therapeutics, Inc. (SLNO) click here.

You May Also Be Interested In

• Tesla Crash Into Texas Home Now Under Federal Safety Probe - WSJ
• Meta pauses an AI training program that tracks employees' keystrokes after a companywide leak - Insider
• Montana-Dakota Utilities signs power deal with Applied Digital for 430 MW AI campus